Actively Recruiting
Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis
Led by Zagazig University · Updated on 2026-04-23
36
Participants Needed
1
Research Sites
124 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
3 groups of patients with onychomycosis will be recruited. Group A will receive itraconazole alone. Group B will receive itraconazole + low dose isotretinoin and group C will be treated with itraconazole + excimer light sessions.
CONDITIONS
Official Title
Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of dermatophyte onychomycosis confirmed by KOH examination and fungal culture
- At least 1 month washout from any previous onychomycosis therapy
- Age between 18 and 60 years
You will not qualify if you...
- Pregnancy or breastfeeding
- Active infection or inflammation in or around nails other than onychomycosis
- Liver disease
- Heart disease
- Diabetes mellitus
- Current use of statin therapy or photosensitizing drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zagazig University Hospitals
Zagazig, Zagazig, Egypt, 44519
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here